YHYang Hu

Yang Hu

*This is an algorithmically generated author record based on publicly available information.

Yang Hu has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Qi Sun

    Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA

    11 shared publications
  • Frank B Hu

    Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States

    5 shared publications
  • Jun Li

    Department of Medicine, Harvard Medical School, Boston, MA, USA

    4 shared publications
  • Liming Liang

    Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, United States

    4 shared publications
  • Frank B. Hu

    Department of Nutrition, Harvard T.H. Chan School of Public Health 1 , Boston, MA

    3 shared publications
  • Gang Liu

    Department of Nutrition and Food Hygiene, Huazhong University of Science and Technology School of Public Health, Wuhan, China

    3 shared publications

Latest Publications

  • Open Access

    Plasma Metabolomic Signature of the Planetary Health Diet and Risk of Cardiovascular Disease and Mortality: A Prospective Cohort Study

    by Naixin Zhang, Anne-Julie Tessier, Fenglei Wang, Jie Hu, Yang Hu, Linh P. Bui, Jun Li, Liming Liang, JoAnn E. Manson, Lu Qi, et al.

    Background: The Planetary Health Diet Index (PHDI) quantifies adherence to the planetary health diet, aiming to promote human health and environmental sustainability. While self-reported PHDI is linked to lower cardiometabolic risk, the underlying biological pathways remain unclear. We aimed to identify a metabolomic signature of PHDI and evaluate its association with cardiovascular disease (CVD) and mortality.Methods: In this prospective cohort study, we included 11,190 adults from three US cohorts (Nurses’ Health Study [NHS], NHS II, and Health Professionals Follow-up Study) with up to 30 years of follow-up. Self-reported PHDI and covariates, including body-mass index (BMI), sociodemographic, and lifestyle factors, were derived from the two questionnaires closest to blood draw. Plasma metabolites were profiled using liquid chromatography-tandem mass spectrometry. We used elastic net regression to identify a metabolomic signature of the PHDI. Associations with incident CVD (1,861 events) and mortality (3,788 deaths) were assessed using Cox proportional hazards models. Findings were replicated in the Women’s Health Initiative (WHI; n=1,711).Findings: We identified an 84-metabolite signature of PHDI (Pearson r=0·46), characterised by higher long-chain highly unsaturated lipids and plant-related amino acids and lower carnitines and saturated lipid species, reflecting favourable lipid remodelling and oxidative stress modulation. Higher metabolomic PHDI was associated with lower risks of CVD (hazard ratio [HR] per 1-SD increment 0·95 [95% CI 0·90-1·00]) and total mortality (0·93 [0·89-0·96]), independently of self-reported PHDI, BMI, and other conventional risk factors. The signature was replicated in WHI for CVD (0·92 [0·84-1·00]).Interpretation: We identified and validated a metabolomic signature of PHDI that captures biological pathways linking adherence to a sustainable dietary pattern with cardiovascular health. These findings provide mechanistic insight into the potential cardiometabolic benefits of the planetary health diet and identify metabolic pathways that could inform future prevention strategies.

  • Low-Carbohydrate Diets of Varying Macronutrient Quality and Risk of Type 2 Diabetes in Three U.S. Prospective Cohort Studies

    by Binkai Liu, Yeli Wang, Yang Hu, Yi Wan, Cuilin Zhang, Eric B. Rimm, Frank B. Hu, Qi Sun

    OBJECTIVE: To prospectively examine associations between five low-carbohydrate diets (LCDs), differentiated by macronutrient quality, and type 2 diabetes (T2D) risk. RESEARCH DESIGN AND METHODS: This cohort study included 199,006 U.S. adults from the Nurses’ Health Study (NHS) (1984–2018), NHSII (1991–2019), and Health Professionals Follow-up Study (1986–2018); free of T2D, cardiovascular disease, and cancer at baseline; and followed over 30 years. Diet was assessed every 2–4 years using validated food frequency questionnaires since baseline. Five LCD scores were derived based on intakes of protein, fat, and carbohydrates from contrasting food sources. The primary outcome was incident T2D. RESULTS: During 4,987,761 person-years of follow-up, 20,452 T2D cases were documented. After adjustments for baseline BMI and other covariates, higher overall LCD score was associated with higher T2D risk (hazard ratio comparing highest vs. lowest quintile 1.31 [95% CI 1.25–1.37]; P-trend < 0.001). An animal-based LCD emphasizing animal protein and fat and an unhealthy LCD score further deemphasizing whole grains and other high-quality carbohydrates were associated with higher T2D risk (1.39 [1.32–1.45] and 1.44 [1.37–1.51]; both P-trend < 0.001). In contrast, a vegetable-based LCD emphasizing plant protein and fat was associated with a 6% lower T2D risk (0.94 [0.90–0.98]; P-trend = 0.004), and a healthy LCD further deemphasizing refined carbohydrates was associated with a 16% lower T2D risk (0.84 [0.81–0.88]; P-trend < 0.001]). Associations for overall, animal-based, and unhealthy LCDs were stronger among participants with lower baseline BMI and were partially mediated by weight change. CONCLUSIONS: LCDs may not be beneficial for primary prevention of T2D unless they prioritize plant-based protein, healthy fats, and high-quality carbohydrates.


  • Calibration of citrus intake assessed by food frequency questionnaires using urinary proline betaine in an observational study setting

    by Yang Hu, Molin Wang, Walter C Willett, Meir Stampfer, Liming Liang, Frank B Hu, Eric Rimm, Lorraine Brennan, Qi Sun


  • Interplay between diet, circulating indolepropionate concentrations and cardiometabolic health in US populations

    by Yang Hu, Jun Li, Biqi Wang, Lu Zhu, Yanping Li, Kerry L Ivey, Kyu Ha Lee, A Heather Eliassen, Andrew Chan, Curtis Huttenhower, et al.

    Objectives: To identify indolepropionate (IPA)-predicting gut microbiota species, investigate potential diet–microbiota interactions, and examine the prospective associations of circulating IPA concentrations with type 2 diabetes (T2D) and coronary heart disease (CHD) risk in free-living individuals. Design: We included 287 men from the Men’s Lifestyle Validation Study, a substudy of the Health Professionals Follow-Up Study (HPFS), who provided up to two pairs of faecal samples and two blood samples. Diet was assessed using 7-day diet records. Associations between plasma concentrations of tryptophan metabolites and T2D CHD risk were examined in 13 032 participants from Nurses’ Health Study (NHS), NHSII and HPFS. Results: We identified 17 microbial species whose abundance was significantly associated with plasma IPA concentrations. A significant association between higher tryptophan intake and higher IPA concentrations was only observed among men who had higher fibre intake and a higher microbial species score consisting of the 17 species (p-interactionQ5 vs Q1 ranged from 1.17 to 1.46) while a significant inverse association was found for IPA (HR Q5 vs Q1 (95% CI) 0.70 (0.56 to 0.88)). No associations were found in CHD for any plasma tryptophan metabolites. Conclusions: Specific microbial species and dietary fibre jointly predicted significantly higher circulating IPA concentrations at higher tryptophan intake. Dietary and plasma tryptophan, as well as its kynurenine pathway metabolites, demonstrated divergent associations from those for IPA, which was significantly predictive of lower risk of T2D.


  • Open Access

    Low-Carbohydrate Diet Scores and Mortality Among Adults With Incident Type 2 Diabetes

    by Yang Hu, Gang Liu, Edward Yu, Biqi Wang, Clemens Wittenbecher, JoAnn E. Manson, Eric B. Rimm, Liming Liang, Kathryn Rexrode, Walter C. Willett, et al.

    OBJECTIVE: The current study aims to prospectively examine the association between postdiagnosis low-carbohydrate diet (LCD) patterns and mortality among individuals with type 2 diabetes (T2D).RESEARCH DESIGN AND METHODS: Among participants with incident diabetes identified in the Nurses’ Health Study and Health Professionals Follow-up Study, an overall total LCD score (TLCDS) was calculated based on the percentage of energy as total carbohydrates. In addition, vegetable (VLCDS), animal (ALCDS), healthy (HLCDS), and unhealthy (ULCDS) LCDS were further derived that emphasized different sources and quality of macronutrients. Multivariable-adjusted Cox models were used to assess the association between the LCDS and mortality.RESULTS: Among 10,101 incident T2D cases contributing 139,407 person-years during follow-up, we documented 4,595 deaths of which 1,389 cases were attributed to cardiovascular disease (CVD) and 881 to cancer. The pooled multivariable-adjusted hazard ratios (HRs, 95% CIs) of total mortality per 10-point increment of postdiagnosis LCDS were 0.87 (0.82, 0.92) for TLCDS, 0.76 (0.71, 0.82) for VLCDS, and 0.78 (0.73, 0.84) for HLCDS. Both VLCDS and HLCDS were also associated with significantly lower CVD and cancer mortality. Each 10-point increase of TLCDS, VLCDS, and HLCDS from prediagnosis to postdiagnosis period was associated with 12% (7%, 17%), 25% (19%, 30%), and 25% (19%, 30%) lower total mortality, respectively. No significant associations were observed for ALCDS and ULCDS.CONCLUSIONS: Among people with T2D, greater adherence to LCD patterns that emphasize high-quality sources of macronutrients was significantly associated with lower total, cardiovascular, and cancer mortality.


  • Open Access

    Weight loss strategies, weight change, and type 2 diabetes in US health professionals: A cohort study

    by Keyi Si, Yang Hu, Molin Wang, Caroline M. Apovian, Jorge E. Chavarro, Qi Sun

    Background: Weight loss is crucial for disease prevention among individuals with overweight or obesity. This study aimed to examine associations of weight loss strategies (WLSs) with weight change and type 2 diabetes (T2D) risk among US health professionals. Methods and findings: This study included 93,110 participants (24 to 60 years old; 11.6% male) from the Nurses’ Health Study (NHS), NHSII, and Health Professionals Follow-Up Study (HPFS) cohorts who were free of T2D, cardiovascular disease, and cancer at baseline (1988 for NHS/HPFS and 1989 for NHSII) for analyses of weight change and 104,180 (24 to 78 years old; 14.2% male) for T2D risk assessment. WLSs used to achieve an intentional weight loss of 4.5+ kg were collected in 1992 (NHS/HPFS)/1993 (NHSII) and grouped into 7 mutually exclusive categories, including low-calorie diet, exercise, low-calorie diet and exercise, fasting, commercial weight loss program (CWLP), diet pills, and FCP (selected at least 2 methods from fasting, CWLP, and pill). The reference group was participants who did not attempt to lose weight. Generalized estimating equations and Cox regression were applied to estimate up to 10-year weight change trajectory and incident T2D risk through 2016 (NHS/HPFS)/2017 (NHSII), respectively. The associations of WLSs with weight change and T2D risk were differential by baseline body weight (Pinteraction < 0.01). Among individuals with obesity, all WLSs tended to associate with less weight gain [ranging from −4.2% (95% confidence interval (CI), −5.1% to −3.2%; P < 0.001) for exercise to −0.3% (−1.2% to 0.7%; P > 0.99) for FCP] and a lower T2D risk [hazard ratios (HRs) ranging from 0.79 (0.66 to 0.95; P = 0.04) for exercise to 0.87 (0.66 to 1.13; P = 0.30) for pill]. Such a pattern was less clear among overweight individuals: the difference of weight change varied from −2.5% (−3.0% to −2.1%; P < 0.001) for exercise to 2.0% (1.3% to 2.7%; P < 0.001) for FCP, and HRs of T2D varied from 0.91 (0.77 to 1.07; P = 0.29) for exercise to 1.42 (1.11 to 1.81; P = 0.02) for pill. The pattern was further inverted among lean individuals in that weight change ranged from −0.4% (−0.6% to −0.1%; P = 0.02) for exercise to 3.7% (3.1% to 4.3%; P < 0.001) for FCP, and the HRs of T2D ranged from 1.09 (0.91 to 1.30; P = 0.33) for exercise to 1.54 (1.13 to 2.10; P = 0.008) for pill. Approximately 15.6% to 46.8% of the association between WLSs and the T2D risk was attributed to weight changes. This study was limited by a single assessment of WLSs, heterogeneity within each WLS, and potential misclassification of the timing of weight loss and weight regain. Conclusions: The current study showed that individuals with obesity who attempted to lose weight, regardless of the WLSs used, tended to gain less body weight and have a lower diabetes risk. In contrast, lean individuals who intentionally lost weight tended to gain more weight and have a higher diabetes risk. These data support the notion that intentional weight loss may not be beneficial for lean individuals and the use of WLSs for achieving weight loss shall be guided by medical indications only.


  • Endoscopic Screening and Risk of Colorectal Cancer according to Type 2 Diabetes Status

    by Kai Wang, Wenjie Ma, Yang Hu, Markus Dines. Knudsen, Long H. Nguyen, Kana Wu, Kimmie Ng, Molin Wang, Shuji Ogino, Qi Sun, et al.

    Current recommendations for colorectal cancer screening have not accounted for type 2 diabetes (T2D) status. It remains unknown whether the colorectal cancer–preventive benefit of endoscopic screening and the recommended age for screening initiation differ by T2D. Among 166,307 women (Nurses’ Health Study I and II, 1988–2017) and 42,875 men (Health Professionals Follow-up Study, 1988–2016), endoscopic screening and T2D diagnosis were biennially updated. We calculated endoscopic screening-associated hazard ratios (HR) and absolute risk reductions (ARR) for colorectal cancer incidence and mortality according to T2D, and age-specific colorectal cancer incidence according to T2D. During a median of 26 years of follow-up, we documented 3,457 colorectal cancer cases and 1,129 colorectal cancer deaths. Endoscopic screening was associated with a similar HR of colorectal cancer incidence in the T2D and non-T2D groups (P-multiplicative interaction = 0.57). In contrast, the endoscopic screening-associated ARR for colorectal cancer incidence was higher in the T2D group (2.36%; 95% CI, 1.55%–3.13%) than in the non-T2D group (1.73%; 95% CI, 1.29%–2.16%; P-additive interaction = 0.01). Individuals without T2D attained a 10-year cumulative risk of 0.35% at the benchmark age of 45 years, whereas those with T2D reached this threshold risk level at the age of 36 years. Similar results were observed for colorectal cancer mortality. In conclusion, the absolute benefit of endoscopic screening for colorectal cancer prevention may be substantially higher for individuals with T2D compared with those without T2D. Although T2D is comparatively rare prior to the fifth decade of life, the rising incidence of young-onset T2D and heightened colorectal cancer risk associated with T2D support the consideration of earlier endoscopic screening in individuals with T2D. Prevention Relevance: The endoscopic screening-associated ARRs for colorectal cancer incidence and mortality were higher for individuals with T2D than those without T2D. Endoscopic screening confers a greater benefit for colorectal cancer prevention among T2D individuals, who may also benefit from an earlier screening than the current recommendation.


  • Open Access

    Polygenic scores, diet quality, and type 2 diabetes risk: An observational study among 35,759 adults from 3 US cohorts

    by Jordi Merino, Marta Guasch-Ferré, Jun Li, Wonil Chung, Yang Hu, Baoshan Ma, Yanping Li, Jae H. Kang, Peter Kraft, Liming Liang, et al.

    Background: Both genetic and lifestyle factors contribute to the risk of type 2 diabetes, but the extent to which there is a synergistic effect of the 2 factors is unclear. The aim of this study was to examine the joint associations of genetic risk and diet quality with incident type 2 diabetes.Methods and findings: We analyzed data from 35,759 men and women in the United States participating in the Nurses’ Health Study (NHS) I (1986 to 2016) and II (1991 to 2017) and the Health Professionals Follow-up Study (HPFS; 1986 to 2016) with available genetic data and who did not have diabetes, cardiovascular disease, or cancer at baseline. Genetic risk was characterized using both a global polygenic score capturing overall genetic risk and pathway-specific polygenic scores denoting distinct pathophysiological mechanisms. Diet quality was assessed using the Alternate Healthy Eating Index (AHEI). Cox models were used to calculate hazard ratios (HRs) for type 2 diabetes after adjusting for potential confounders. With over 902,386 person-years of follow-up, 4,433 participants were diagnosed with type 2 diabetes. The relative risk of type 2 diabetes was 1.29 (95% confidence interval [CI] 1.25, 1.32;P< 0.001) per standard deviation (SD) increase in global polygenic score and 1.13 (1.09, 1.17;P< 0.001) per 10-unit decrease in AHEI. Irrespective of genetic risk, low diet quality, as compared to high diet quality, was associated with approximately 30% increased risk of type 2 diabetes (Pinteraction= 0.69). The joint association of low diet quality and increased genetic risk was similar to the sum of the risk associated with each factor alone (Pinteraction= 0.30). Limitations of this study include the self-report of diet information and possible bias resulting from inclusion of highly educated participants with available genetic data.Conclusions: These data provide evidence for the independent associations of genetic risk and diet quality with incident type 2 diabetes and suggest that a healthy diet is associated with lower diabetes risk across all levels of genetic risk.


  • Open Access

    Correction to: The diagnostic value of transbronchial lung cryobiopsy combined with rapid on-site evaluation in diffuse lung diseases: a prospective and self-controlled study

    by Xianqiu Chen, Jie Luo, Li Yang, Likun Hou, Bing Jie, Yang Hu, Jianxiong Li, Xing Jiang, Jinfu Xu, Kebin Cheng

  • Open Access

    Weight Gain After Smoking Cessation and Cancer Risk in 3 Prospective Cohorts in the United States

    by Yang Hu, Geng Zong, Qi Sun, Edward Giovannucci, Mingyang Song

    It remains unknown how cancer risks vary by duration of smoking cessation and whether the benefit is attenuated by postcessation weight gain. We prospectively followed 198 565 persons from the Nurses’ Health Study (1978-2016), Nurses’ Health Study II (1991-2017), and Health Professionals Follow-up Study (1988-2016) who were free of cancer at baseline. We used proportional hazard Cox models to compare cancer risk between current smokers and former smokers with different durations of smoking cessation and postcessation weight gains. During 4 718 199 person-years of follow-up, we identified 32 456 cases of total cancer. Compared with current smokers, the risks for total and smoking-related cancer in past smokers were reduced to the level similar to never smokers after abstaining smoking for more than 26 years, with the hazard ratio of 0.69 (95% confidence interval [CI] = 0.63 to 0.76) for total cancer and 0.31 (95% CI = 0.26 to 0.37) for smoking-related cancer, whereas no risk reduction was found for obesity-related cancer. Comparing former smokers with current smokers, the multivariable-adjusted hazard ratios for postcessation weight gain of 0-4.9 kg, 5-9.9 kg, and 10 kg or higher were 0.85 (95% CI = 0.81 to 0.89), 0.88 (95% CI = 0.83 to 0.93), and 0.93 (95% CI = 0.88 to 1.00) for total cancer and 0.62 (95% CI = 0.58 to 0.67), 0.65 (95% CI = 0.60 to 0.71), and 0.71 (95% CI = 0.65 to 0.78) for total smoking-related cancer. In contrast, higher weight gain following smoking cessation was associated with a modest increased obesity-related cancer risk. Smoking cessation overall has a strong net association with lower risk of total cancer irrespective of weight gain. However, this inverse association may be attenuated by substantial postcessation weight gain, largely because of an increased risk of obesity-related cancers.